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Introduction
Syngeneic mouse models of breast cancer offer the
researcher an important tool with which to investigate the
molecular mechanisms of cancer. These models generally
arise through the isolation of breast cancer cells from
spontaneous breast tumours in mice. As the cells have ori-
ginated from a spontaneous tumour, they are immunologi-
cally and genetically compatible to a more clinically
relevant breast cancer model. The aim of this study was to
characterise newly isolated Spontaneous Mammary
Tumour (SMT1) cells and its matched lung metastatic
cells (SMT1L) from a spontaneous mammary tumour that
arose in a 2 year old female BALB/c mouse.
Methods
SMT1 and SMT1L cells were cultured in DMEM High
Glucose supplemented with 10% FBS. Western blot analy-
sis using cell lysates from SMT cells was used to confirm
that cells were of epithelial origin, to characterise the cells
for biomarkers of breast cancer subtypes: oestrogen recep-
tor , progesterone receptor, ErbB2 (Her2) and Epidermal
Growth Factor Receptor (EGFR) expression and to verify
expression of the Insulin-like Growth Factor (IGF) path-
way (the IGF receptor (IGF-IR) and Insulin Receptor (IR)).
RT-PCR was used to confirm if SMT cells express Preg-
nancy-Associated Plasma Protein A (PAPP-A), a regulator
of IGFBP4. The growth rates and effect of IGF-1 on
growth of both SMT cell lines were compared by SRB pro-
liferation assay.
Results
SMT1 and SMT1L cells are of epithelial origin. SMT cell
types expressed HER2, EGFR, and PR suggesting a more
aggressive phenotype. The lack of ER positivity confirms
this is not the main pathway of signalling in SMT cells.
SMT cells express features of the IGF pathway including
IR-b, IGF-1Rb and PAPP-A. SMT1 and SMT1L prolifera-
tion rates in vitro were similar, with both cell lines
responding to IGF-1 stimulation showing increased
growth compared to untreated controls.
Conclusions
Based on expression of common biomarkers of breast can-
cer subtypes, SMT cells may be more aggressive cell line.
Expression of members of the IGF pathway and response
to IGF-I stimulation indicates that inhibiting IGF may be
of value in inhibiting growth of SMT tumours, and It may
offer another preclinical syngeneic model of breast cancer.
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